In summary, we revealed, for the first time, that DGKα is involved in the effect of EGCg on DN in vivo, and showed that, via activating DGKα, EGCg protected the loss of podocytes by preventing focal adhesion decreases. This evidence concerns the gene DGKA and liver dysplastic nodule.